Provexis PLC
14 November 2007
PROVEXIS PLC
('Provexis' or the 'Company')
Provexis and Unilever renew Fruitflow(R) Exclusivity Agreement
Provexis, developer of scientifically-proven functional food, dietary supplement
and medical food technologies, announces that it has progressed its exclusivity
agreement with Unilever plc on to look specifically at how Provexis might
develop a new format of its patented Fruitflow(R) heart-health technology for
potential application in Unilever's spread product portfolio.
Fruitflow(R) is a patented natural extract from tomato which has been shown in
human trials to reduce the propensity for aberrant blood clotting, typically
associated with cardiovascular disease, which can lead to heart attack or
stroke. Unilever has substantial global brands in the heart-health market,
primarily its Flora/Becel spreads and drinking yoghurts, which have sales in
excess of €1bn.
The partners have successfully developed a pilot-scale version of the new
concentrated format over the past year, which subsequently showed positive
results in a recent human trial. Under the terms of new agreement, which extends
for 12 months, Provexis will now further develop this new technology to deliver
a product suitable for potential incorporation into vegetable-oil based fat
spreads. Unilever will transfer certain manufacturing assets to Provexis to
facilitate this phase of the project.
There are four sectors in which Provexis is seeking major partnerships, namely,
food and dairy, beverages, products for deep vein thrombosis, and dietary
supplements and medical products.
Commenting on the renewal of the collaboration agreement, Stephen Moon, CEO of
Provexis, said: 'We are pleased with the progress made over the last year and
are now focusing on delivering this important new format in a product suitable
for Unilever's spread range.'
For further information please contact:
Stephen Moon, CEO
Provexis plc Tel: 01753 752290
Tom Griffiths / Alasdair Younie
Arbuthnot Securities Tel: 020 7012 2000
Chris Steele
Adventis Financial PR Tel: 020 7034 4759
END
Notes:
About Unilever
Unilever's mission is to add vitality to life. It meets everyday needs for
nutrition, hygiene and personal care with brands that help people feel good,
look good and get more out of life.
Unilever is one of the world's leading suppliers of fast moving consumer goods
with strong local roots in more than 100 countries across the globe. Its
portfolio includes some of the world's best known and most loved brands
including twelve €1 billion brands and global leadership in many categories in
which the company operates. The portfolio features brand icons such as Flora,
Bertolli, Dove, Lux, Pond's, Lynx, Sunsilk, Persil, Cif and Domestos.
Unilever has around 179,000 employees in approaching 100 countries and generated
annual sales of €40 billion in 2006. For more information about Unilever and its
brands, visit www.unilever.com.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.